
New
ScienceMore in Science→
MKD study finds immune-cell flaw and treatment lead
Key Takeaways
- A study in Immunity identifies malfunctioning natural killer cells in mevalonate kinase deficiency.
- The finding challenges a disease model that has focused on macrophages for about three decades.
- JAK inhibitors and approaches targeting interferon gamma are proposed for future clinical study.
DE
DT Editorial Team··via sciencedaily.com